These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 27328763

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, Fukushima C, Yamamoto H, Kawakami A.
    Trials; 2018 Dec 29; 19(1):715. PubMed ID: 30594222
    [Abstract] [Full Text] [Related]

  • 23. Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.
    Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y.
    J Nephrol; 2018 Jun 29; 31(3):453-455. PubMed ID: 29446001
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S.
    Arthritis Res Ther; 2015 Sep 04; 17(1):243. PubMed ID: 26337145
    [Abstract] [Full Text] [Related]

  • 25. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.
    Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, Sengul S, Keven K.
    Transplant Proc; 2019 Sep 04; 51(7):2292-2294. PubMed ID: 31400972
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ben-Zvi I, Kukuy O, Giat E, Pras E, Feld O, Kivity S, Perski O, Bornstein G, Grossman C, Harari G, Lidar M, Livneh A.
    Arthritis Rheumatol; 2017 Apr 04; 69(4):854-862. PubMed ID: 27860460
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.
    Atas N, Eroglu GA, Sodan HN, Ozturk BO, Babaoglu H, Satis H, Karadeniz H, Guler AA, Salman RB, Goker B, Ozturk MA, Haznedaroglu S, Tufan A.
    Clin Exp Rheumatol; 2021 Apr 04; 39 Suppl 132(5):30-36. PubMed ID: 34251317
    [Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S, Ergezen B, Egeli BH, Selvi O, Ozdogan H.
    Rheumatology (Oxford); 2020 Dec 01; 59(12):3892-3899. PubMed ID: 32556219
    [Abstract] [Full Text] [Related]

  • 31. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N.
    Rheumatol Int; 2020 Jan 01; 40(1):161-168. PubMed ID: 31273456
    [Abstract] [Full Text] [Related]

  • 32. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B, Xu T, Li Y, Yin X.
    Cochrane Database Syst Rev; 2015 Mar 20; (3):CD010893. PubMed ID: 25791871
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L, Marchetti F, Tommasini A, Ventura A.
    Eur J Pediatr; 2008 Jun 20; 167(6):695-6. PubMed ID: 17588171
    [Abstract] [Full Text] [Related]

  • 36. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.
    Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I.
    Semin Arthritis Rheum; 2011 Oct 20; 41(2):265-71. PubMed ID: 21277619
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients.
    Başaran Ö, Uncu N, Çelikel BA, Taktak A, Gür G, Cakar N.
    Mod Rheumatol; 2015 Jul 20; 25(4):621-4. PubMed ID: 25528863
    [Abstract] [Full Text] [Related]

  • 40. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S, Atas B.
    J Pak Med Assoc; 2017 Jun 20; 67(6):945-947. PubMed ID: 28585601
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.